Treatment of Hodgkin's disease: The Swedish National Care Programme experience

Leukemia and Lymphoma

Volumn 21, Issue 1-2, 1996, Pages 71-78

  Glimelius, B ^a,g   Enblad, G ^a   Kalkner M ^a   Gustavsson, A ^b   Jakobsson, M ^c   Branehog I ^d   Lenner, P ^e   Bjorkholm M ^f  

^a UPPSALA UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c LINKÖPING UNIVERSITY   (Sweden)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

^e UMEÅ UNIVERSITY   (Sweden)

^f KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^g UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Chemotherapy; Elderly patients; Hodgkin's disease; National care programme; Radiotherapy

Indexed keywords

BLEOMYCIN; CHLORAMBUCIL; CHLORMETHINE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; MITOXANTRONE; PREDNISOLONE; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER STAGING; DRUG FATALITY; FOLLOW UP; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; PATIENT CARE; PRIORITY JOURNAL; PROGNOSIS; SWEDEN; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0030042246     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199609067582     Document Type: Article

References (26)

1. Henry-Amar, M. and Somers, R. (1990) Survival outcome after Hodgkin's disease: a report from the international data base on Hodgkin's disease. Sem. Oncol., 17, 758-768.
2. Urba. W. J. and Longo, D. L. (1992) Hodgkin's disease. New Engl. J. Med., 326, 678-687.
3. Kaplan, H. S. (1980) Hodgkin's disease. Harvard University Press, Cambridge, Massachusetts.
4. Specht, L., Carde, P., and Mauch, P. (1992) Radiotherapy versus combined modality in early stages. Ann. Oncol., 3, Suppl 4, 77-82.
5. Kaldor, J. M., Day,N. E., Clarke, A. E., Van Leeuwen, F. E., Henry-Amar, M., Fiorentino, M. V., Bell, J., Pedersen, D., Band. P., Assouline, D., Koch, M., Choi, W., Prior, P., Blair, V., Langmark, F., Pompe Kirn, V., Neal, F., Peters, D., Pfeiffer, R., Karjalainen. S., Cuzick, J., Sutcliffe, S. B., Somers, R., Pellae-Cosset, B., Pappagallo. G. L., Fraser, P., Storm, H., and Stovall, M. (1990) Leukemia following Hodgkin's disease. N. Engl. J. Med., 322, 7-13.
6. Rubin, P., Zagars, G., Chuang, C., and Thomas, E. M. (1986) Hodgkin's disease: is there a price for successful treatment? A 25-year experience. Int. J. Radiat. Oncol. Biol. Phys., 12, 153-166.
7. Tubiana, M., Henry-Amar, M., Carde, P., Burgers, J. M. V, Hayat, M., Van der Schueren, E., Noordijk, E. M., Tanguy, A., Meerwaldt, J. H., Thomas, J., De Pauw, B., Monconduit, M., Cosset, J. M., and Somers, R. (1989) Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group Controlled Clinical Trials: 1964-1987. Blood, 73, 47-56.
8. DeVita, V. T. and Hubbard, S. M. (1993) Hodgkin's disease. New Engl. J. Med., 328, 560-565.
9. Carbone, P. P., Kaplan, H. S., Musshoff, K., Smithers, D. W., and Tubiana, M. (1971) Report of the committee on Hodgkin's disease staging. Cancer Res., 31, 1860-1861.
10. Lister, T. A., Crowther, D., Sutcliffe, S. B., Glatstein, E., Canellos, G. P., Young, R. C., Rosenberg, S. A., Coltman, C. A., and Tubiana, M. (1989) Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J. Clin. Oncol., 7, 1630-1636. [Erratum, (1990) J. Clin. Oncoi., 8, 1602]
11. Hagemeister, F. B.,Tannir, N., McLaughlin, P., Salvador, P., Riggs, S., Velasques, W. S., and Cabanillas, F. (1987) MIME chemotherapy (Methyl-GAG. Ifosfamide, Methotrexate, Etoposide) as treatment for recurrent Hodgkin's disease. J. Clin. Oncol., 5, 556-561.
12. Viviani, S., Santoro, A., Negretti, E., Bonfante, V., Valagussa, P., and Bonadonna, G. (1990) Sal vage chemotherapy in Hodgkin's disease. Ann. Oncol., 1, 123-127.
13. Selby, P., McElwain, T. J., and Canellos, G. (1987) Chemotherapy for Hodgkin's disease. Section I: MOPP and its variants. In Hodgkin's Disease edited by P Selby and TJ McElwain, pp 270-285, Blackwell Scientific Publications.
14. Enblad, G., Glimelius, B., and Sundström, C. (1991) Treatment outcome in Hodgkin's disease in patients above the age of 60: A population based study. Ann. Oncol., 2, 297-302.
15. Norberg, B., Dige, U., Roos, H., Johansson, H., and Lenner, P. (1991) Hodgkin's disease in northern Sweden 1971-1981. Acta. Oncot.. 6, 697-701.
16. Glimelius, B. and Enblad, G. (1990) Hodgkins disease. In Cancer and aging. Edited by A Macieira-Coelho, and B Nordenskjöld, pp 227-238.
17. Glimelius, B., Kälkner, M., Enblad, G., Gustavsson, E., Jakobsson. M., Branehög, I., and Lenner, P. for the Swedish Lymphoma Study Group. (1994) Treatment of early and intermediate stages of supradiaphragmatic Hodgkin's disease: The Swedish Nation Care Programme Experience. Ann. of Oncol., 5, 809-816.
18. Schewe, K. L., Reavis, J., Kun, L. E., and Cox, J. D. (1988) Total dose, fraction size, and tumor volume in the local control of Hodgkin's disease. Int. J. Rad. Oncol. Biol. Phys., 15, 25-28.
19. Viayakumar, S. and Myrianthopoulos, L. C. (1992) An updated dose-response analysis in Hodgkin's disease. Radiother. Oncol.,24, 1-13.
20. Canellos, G. P., Anderson, J. R., Propert, K., Nissen, N., Cooper, M. R., Henderson, E. S., Green, M. R., Gotlieb, A., and Peterson, B. A. (1992) Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD or MOPP alternating with ABVD. N. Engl. J. Med., 21, 1478-1484.
21. Somers, R., Carde, P., Henry-Amar, M., Tarayre, M., Thomas, J., Hagenbeek, A., Monconduit, M., de Pauw, B. E., Breed, W. P. M., Verdonck, L., Burgers, J.M.V., Eghbali, H.,and Zittoun, R.(1994) A randomized study in stage IIIB and IV Hodgkin's disease comparing eight courses of MOPP versus an alternation of MOPP with ABVD: A European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group and Groupe Pierre-et-Marie-Curie Controlled Clinical Trial. J. Clin. Oncol., 12, 279-287.
22. DeVita, V. T. (1993) Is alternating cyclic chemotherapy better than standard four-drug chemotherapy for Hodgkin's disease? No. Principles and Practice of Oncology, 1, 1-11.
23. Connors, J. M. (1993) Is cyclical chemotherapy better than standard four drug chemotherapy for Hodgkin' s disease? Yes. Principles and Practice of Oncology, 2, 1-6.
24. Connors, J. M. and Klimo, P. (1987) MOPP/ABV hybrid chemotherapy for advanced Hodgkin's disease. Semin. Hematol., 24, 35-40.
25. Carella, A. M., Carlier, P., Congiu, A., Occhini, D., Nati, S., Santini, G., Pierluigi, D., Giordano, D., Bacigalupo, A., and Damasio, E. (1991) Autologous bone marrow transplantation as adjuvant treatment for high-risk Hodgkin's disease in first complete remission after MOPP/ABVD protocol. Bone Marrow Transpl., 8, 99-103.
26. DeVita, V. T. Jr, Simon, R. M., Hubbard, S. M. et al. (1980) Curability of advanced Hodgkin's disease with chemotherapy. Ann. Intern. Med., 92, 587-595.